GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 124 filers reported holding GOSSAMER BIO INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -40.0% | 4 | 0.0% | 0.00% | – |
| Q2 2023 | $5 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | -100.0% | 4 | -100.0% | 0.00% | – |
| Q4 2022 | $34,670 | -77.6% | 15,977 | +23.6% | 0.00% | -100.0% |
| Q3 2022 | $155,000 | +43.5% | 12,927 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $108,000 | -6.1% | 12,927 | -2.0% | 0.00% | 0.0% |
| Q1 2022 | $115,000 | -2.5% | 13,193 | +26.6% | 0.00% | 0.0% |
| Q4 2021 | $118,000 | -9.9% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $131,000 | +54.1% | 10,421 | 0.0% | 0.00% | – |
| Q2 2021 | $85,000 | -11.5% | 10,421 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $96,000 | -5.0% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $101,000 | -21.7% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $129,000 | -4.4% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $135,000 | +365.5% | 10,421 | +264.8% | 0.00% | – |
| Q1 2020 | $29,000 | -35.6% | 2,857 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | – | 2,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |